UNSPSC 51332866: Perphenazine maleate

This classification denotes an antipsychotic agent with the molecular formula C21H26ClN3OS.2C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7K96LZ09JI, chemically known as 1-piperazineethanol, 4-(3-(2-chloro-10h-phenothiazin-10-yl)propyl)-, (2z)-2-butenedioate (1:2) (salt), but more generally known as perphenazine maleate, which bears US NIH Compound Identifier 6442084.

European Medicines Agency schedules perphenazine maleate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09736MIG. Most nations, for tariff purposes, schedule perphenazine maleate under HS 29343090. SMILES: C1CC2C(CC1)SC3C(CC(CC3)CL)N2CCCN4CCN(CC4)CCO.C(=C\C(=O)O)\C(=O)O.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51332866 Perphenazine maleate is a Commodity code, but recent state and local solicitations tagged with this code show minimal alignment with the specific pharmaceutical product. The three recent opportunities posted under or near this code involve naloxone distribution, direct-to-manufacturer pharmacy initiatives, and multi-source generic pharmaceuticals through cooperative purchasing — none explicitly soliciting perphenazine maleate itself. The issuing bodies span a county health department (Seminole County, Florida), a state health and human services commission (Texas HHS Commission), and a multi-state cooperative purchasing alliance administered by a state department of administration (MMCAP, Minnesota). The work being solicited includes procurement of naloxone and safe drug deactivation systems for community health initiatives, exploratory market intelligence on direct pharmacy contracting models, and establishment of framework agreements for generic pharmaceuticals and OTC products distributed through authorized wholesalers with fixed pricing and tiered administrative fees.

Recent activity appears concentrated in Florida, Texas, and the MMCAP member states (primarily Minnesota and Oregon). Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2026. The Texas HHS Commission posted Request for Information HHS0017013 on April 3, 2026, to gather vendor capabilities for a therapeutic pharmacy initiative involving direct-to-manufacturer prescription programs — an exploratory phase intended to inform future formal solicitation design rather than a binding competitive bid. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 on January 20, 2026, establishing multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities, with proposals due March 26, 2026, and contract effectiveness targeted for July 1, 2026. The mismatch between the code's nominal scope (perphenazine maleate, a specific antipsychotic) and the actual work solicited (broad pharmaceutical procurement, naloxone distribution, and pharmacy system innovation) suggests this code shows little relevant recent activity for the specific product.